Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Christensen

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Plos Pathogens|May 10, 2013
An extracellular siderophore is required to maintain the mutualistic interaction of Epichloë festucae with Lolium perenneLinda J Johnson, Albert Koulman, Michael Christensen, et al.
Animal Models and Experimental Medicine|November 13, 2025
Temporal glomerular gene expression dynamics during disease progression in a mouse model of hypertension-accelerated diabetic kidney diseaseAdam B Marstrand-Jørgensen, Frederikke Emilie Sembach, Maria Ougaard, et al.
American Journal of Physiology. Renal Physiology|June 28, 2021
Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney diseaseMette V Østergaard, Thomas Secher, Michael Christensen, et al.
Scientific Reports|October 27, 2016
Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the KidneyMichael Christensen, Jonas B Jensen, Steen Jakobsen, et al.
Biomedicines|July 27, 2022
Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney DiseaseLouise S Dalbøge, Michael Christensen, Martin Rønn Madsen, et al.
British Journal of Pharmacology|October 22, 2025
Deep learning-enhanced 3D imaging unveils semaglutide impact on cardiac fibrosisSheyla Barrado-Ballestero, Sarah Torp Yttergren, Max Hahn, et al.
Journal of Hazardous Materials|February 20, 2024
Blueprint for the design, construction, and validation of a plastic and phthalate-minimised laboratoryCassandra Rauert, Xianyu Wang, Nathan Charlton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2012
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancerAndre Konski, Tianyu Li, Michael Christensen, et al.
European Urology Oncology|January 6, 2022
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney CancerRaquibul Hannan, Michael Christensen, Hans Hammers, et al.
Hippocampus|June 28, 2017
A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticityKatrina Hurst, Corinne Badgley, Tanner Ellsworth, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Plos Pathogens|May 10, 2013
An extracellular siderophore is required to maintain the mutualistic interaction of Epichloë festucae with Lolium perenneLinda J Johnson, Albert Koulman, Michael Christensen, et al.
Animal Models and Experimental Medicine|November 13, 2025
Temporal glomerular gene expression dynamics during disease progression in a mouse model of hypertension-accelerated diabetic kidney diseaseAdam B Marstrand-Jørgensen, Frederikke Emilie Sembach, Maria Ougaard, et al.
American Journal of Physiology. Renal Physiology|June 28, 2021
Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney diseaseMette V Østergaard, Thomas Secher, Michael Christensen, et al.
Scientific Reports|October 27, 2016
Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the KidneyMichael Christensen, Jonas B Jensen, Steen Jakobsen, et al.
Biomedicines|July 27, 2022
Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney DiseaseLouise S Dalbøge, Michael Christensen, Martin Rønn Madsen, et al.
British Journal of Pharmacology|October 22, 2025
Deep learning-enhanced 3D imaging unveils semaglutide impact on cardiac fibrosisSheyla Barrado-Ballestero, Sarah Torp Yttergren, Max Hahn, et al.
Journal of Hazardous Materials|February 20, 2024
Blueprint for the design, construction, and validation of a plastic and phthalate-minimised laboratoryCassandra Rauert, Xianyu Wang, Nathan Charlton, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2012
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancerAndre Konski, Tianyu Li, Michael Christensen, et al.
European Urology Oncology|January 6, 2022
Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney CancerRaquibul Hannan, Michael Christensen, Hans Hammers, et al.
Hippocampus|June 28, 2017
A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticityKatrina Hurst, Corinne Badgley, Tanner Ellsworth, et al.
Pageof 5